EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Therapeutic Efficacy of Albendazole in Neonatal Calves Naturally Infected with Cryptosporidium parvum

Okan Bayrak, Mehmet Can Ulucesme iD, Meryem Toprak Tuncer iD, Munir Aktas iD, Ahmet Atessahin iD

Pathogens · 16.08.2026 · 15 (8) · 854

DOI: 10.3390/pathogens15080854 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens, online erschienen am 16.08.2026. Verfasst von Okan Bayrak und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Fırat University, Elazığ 23119, Türkiye. Hauptthemen laut MEDLINE: Albendazole, Cryptosporidiosis, Cryptosporidium parvum, Cattle Diseases. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Scientific and Technological Research Council of Türkiye.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cryptosporidiosis is a significant zoonotic disease caused by Cryptosporidium species, primarily Cryptosporidium parvum, leading to serious economic losses in neonatal calves; the absence of an approved vaccine or fully effective treatment necessitates alternative therapeutic approaches. This study evaluated the therapeutic efficacy of albendazole (20 mg/kg, orally, 5 days) in naturally infected neonatal calves, comparing it to paromomycin (100 mg/kg, orally, 5 days) and an albendazole + paromomycin combination. Forty-eight Simmental calves (36 naturally infected, mean age of 14 days, and 12 healthy controls) were included. Infection was confirmed by rapid immunochromatographic tests, carbol fuchsin staining, nested PCR, and RFLP, identifying C. parvum as the causative agent. Fecal and blood samples were collected on days 0, 3, 7, 10, 20, and 30, alongside clinical evaluations and live weight measurements. Oocyst shedding declined significantly over the study period in all three treatment groups, with the paromomycin and albendazole + paromomycin groups showing a numerically earlier decline than the albendazole group; however, no statistically significant differences among the three treatment groups were detected at any individual sampling day. Fecal scores paralleled oocyst shedding patterns. No significant differences were detected among treatment groups in hematological, biochemical, or hepatorenal safety parameters. Albendazole demonstrated efficacy in reducing oocyst shedding in Cryptosporidium infection, suggesting it may serve as a viable alternative treatment option in field conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AlbendazoleCryptosporidiosisCryptosporidium parvumCattle DiseasesAntiprotozoal AgentsAnimalsCattleAnimals, NewbornFecesParomomycinTreatment Outcome

Stichwörter der Autor:innen

benzimidazolecryptosporidiosisneonatal calf diarrheaoocyst sheddingtreatment

Substanzen

AlbendazoleAntiprotozoal AgentsParomomycin

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, Faculty of Veterinary Medicine, Fırat University, Elazığ 23119, Türkiye.
  • Department of Parasitology, Faculty of Veterinary Medicine, Fırat University, Elazığ 23119, Türkiye.

ORCID-Profile: Mehmet Can Ulucesme, Meryem Toprak Tuncer, Munir Aktas, Ahmet Atessahin

Förderung

  • The Scientific and Technological Research Council of Türkiye

Zitieren

APA

Bayrak, O., Ulucesme, M. C., Toprak Tuncer, M., Aktas, M., & Atessahin, A. (2026). Therapeutic Efficacy of Albendazole in Neonatal Calves Naturally Infected with Cryptosporidium parvum. Pathogens, 15(8), 854. https://doi.org/10.3390/pathogens15080854

Vancouver

Bayrak O, Ulucesme MC, Toprak Tuncer M, Aktas M, Atessahin A. Therapeutic Efficacy of Albendazole in Neonatal Calves Naturally Infected with Cryptosporidium parvum. Pathogens. 2026;15(8):854. doi:10.3390/pathogens15080854

BibTeX
@article{Bayrak2026,
  author = {Bayrak, Okan and Ulucesme, Mehmet Can and Toprak Tuncer, Meryem and Aktas, Munir and Atessahin, Ahmet},
  title = {Therapeutic Efficacy of Albendazole in Neonatal Calves Naturally Infected with Cryptosporidium parvum},
  journal = {Pathogens},
  year = {2026},
  volume = {15},
  number = {8},
  pages = {854},
  doi = {10.3390/pathogens15080854}
}
Kostenlos starten →